FindDrugs.org

Ro Erectile Dysfunction Review

Erectile Dysfunction · Reviewed Sep 23, 2026

6.83/10
Ro operator trust7.34/10See the full Ro brand review
Insurance-friendlyNo commitmentCash-pay

Our verdict

Ro offers a full range of genuine FDA-approved ED medications — generic and branded sildenafil and tadalafil — alongside its compounded, non-FDA-approved Sparks chewable and Daily Rise gummies. Format flexibility is a real strength; the main watch-outs are pricing that is only partly shown before signup and the heavy promotion of compounded products next to FDA-approved ones.

Price

from $32/mo · 6 plans

Check price

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

Key takeaways

  • Full FDA-approved PDE5 line plus compounded options
  • Generic sildenafil from ~$4/dose; some prices quiz-gated
  • Compounded Sparks/Daily Rise are not FDA-approved

What is Ro Erectile Dysfunction?

Ro's erectile-dysfunction program prescribes FDA-approved PDE5 inhibitors — generic and branded sildenafil and tadalafil — after an online visit with a US-licensed provider, plus its own compounded chewable (Ro Sparks) and daily gummy (Daily Rise). It is a men's sexual-health service, separate from Ro's weight-loss and other categories.

Treatment options

Prices as of Sep 23, 2026 — verify current on the brand's site.

Methodology scorecard

Scored on Sep 23, 2026 under methodology v6

6.83/10

Coverage: Checked against 6 recorded withdrawals. Marking matches the wording each withdrawal was recorded in, so the same claim stated differently is not marked.

One factor could not be established: Legitimacy & Accreditation

We could not establish this from a third-party record. What we searched: accreditation and licensing bodies — LegitScript, NABP including its .pharmacy verification, and URAC — state licensing registries, and the provider’s own corporate disclosures. On LegitScript we read the provider’s own website and never LegitScript’s register: their terms do not permit automated queries to it, so a LegitScript-issued seal found on a provider’s pages establishes that the seal was displayed there on that date, and not that a certification is current. No register, federal or otherwise, answers whether an operation is licensed in every state it ships to; of the six government hosts we read on 2026-08-25, three do not permit us. This is a statement about what we were able to verify, never a finding that the provider lacks accreditation. Where a provider states its own licensure or displays its own seal, that is recorded as the provider’s own claim and lifts no subscore by itself.

Pricing & cancellation

Check price

All-in price

from $32/mo · 6 options

Cost structure
Month-to-month membership with optional prepaid annual plan.
Insurance vs. cash
Cash-pay
Deal structure
Cancellation
Cancel anytime to stop future renewals; membership fee non-refundable once billed for the current cycle.
Forced subscription
Not required

Pros & cons

Pros

  • Genuine clinician review with real prescriber oversight
  • Large, well-funded, high-momentum operator
  • Broad treatment catalog under one account
  • Discreet, free shipping

Cons

  • Membership billed separately from medication cost
  • Pricing frequently gated behind the intake quiz
  • Compounding pharmacies not named in any category
  • Heavy promotion of non-FDA-approved compounded formulations

Safety

Talk to a licensed clinician

PDE5 inhibitors can cause headache, flushing, nasal congestion and, rarely, priapism or vision changes; they are contraindicated with nitrates. Compounded Sparks/Daily Rise are not FDA-approved and do not undergo FDA review — a point Ro discloses.

The bottom line

A strong, flexible ED menu from a legitimate operator. If you want an FDA-approved option, the generic sildenafil/tadalafil are well-priced; weigh the compounded products against their non-FDA-approved status.

Check price

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

See how Ro ranks among ED providers

What changed & why

This brand's own history — every re-review and methodology recompute, logged. Rankings change when the evidence or the rules change, never for payment. See the site-wide methodology ledger for version history.

  1. Sep 14, 2026Methodologymethodology v66.816.83

    We changed how this score is calculated, and Sexual Health / ED score moved from 6.81 to 6.83. 1 of the factors behind it moved. How we score.

    1 factor withdrawn — assessed coverage fell 13 → 12. Part of any score movement here reflects evidence we retracted, not a change in the brand.

  2. Aug 23, 2026Methodologymethodology v37.146.81

    We changed how this score is calculated, and Sexual Health / ED score moved from 7.14 to 6.81. 2 of the factors behind it moved. How we score.

    2 factors withdrawn — assessed coverage fell 15 → 13. Part of any score movement here reflects evidence we retracted, not a change in the brand.

Work at Ro?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Scored on 12 of 14 factors · 10 sources cited

Brand site

Regulatory

Reviews

What we couldn't verify

  • Fulfilling pharmacy and 503A/503B compounding pharmacy are not identified in any record we could retrieve.
  • Privacy/security posture rests on standard HIPAA-covered-telehealth assumptions; no independent audit trail was retrievable.
  • Individual prescribing clinician identities were not found in any record we could retrieve.
  • Withdrawn — Ro is LegitScript-certified. WITHDRAWN. legitscript.com/websites/ro.co/ returns HTTP 200 but serves a reCAPTCHA form shell with no certification status and no mention of ro.co (retrieved 2026-08-13); api.legitscript.com returns 403, seal-ID routes 404, the sitemap is empty, and ro.co's own badge is an unlinked image. The prior citation was the legitscript.com HOMEPAGE, which states nothing about Ro. Retrieval-failed, not disproved — the same test fridays failed with a 403.
  • Withdrawn — Ro funding/revenue figures (raised, valuation, revenue, projections). WITHDRAWN. Sourced only to sacra.com, a market-data aggregator that neither originates nor audits the figures. Ro is private; no filing or audited record is retrievable.
  • Withdrawn — Ro is a "preferred distribution partner" of Novo Nordisk and Eli Lilly. WITHDRAWN. Cited to press/affiliate only. Not re-pointable: novocare.com (200) names Ro on no fetchable page and lillydirect.lilly.com returns HTTP 403 (retrieval-failed). Ro's own claim to source through those channels is retained as company-attested.
  • Withdrawn — Ro surfaces contraindication warnings during intake. WITHDRAWN. A safety-behaviour claim resting on the company's own page; no label or registry record can establish what a telehealth intake surfaces.
  • Withdrawn — Ro operates provider-managed dose titration with starter-dose offerings and ongoing check-ins. WITHDRAWN and the factor EXCLUDED. A dosing claim requires a label or registry record; none describes a telehealth provider's titration practice.
  • Withdrawn — Ro "discloses membership terms, contraindications, and expected outcomes with cited studies". WITHDRAWN. A favourable disclosure-quality claim resting solely on Ro's own page; a label records what the contraindications are, not that Ro surfaces them, so it is not re-pointable (punch list § G9).
Last reviewed Sep 23, 2026 · methodology v6View the ledger

Top pick

Ro 6.83/10